A share price of Conmed Corp [CNMD] is currently trading at $59.43, down -3.24%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CNMD shares have lost -3.07% over the last week, with a monthly amount drifted -16.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Conmed Corp [NYSE: CNMD] stock has seen the most recent analyst activity on February 06, 2025, when JP Morgan downgraded its rating to a Neutral and also revised its price target to $70 from $85. Previously, Needham reaffirmed its Buy rating on February 01, 2024, and elevated its price target to $129. On May 22, 2023, CL King initiated with a Buy rating and assigned a price target of $140 on the stock. KeyBanc Capital Markets upgraded its rating to a Overweight but stick to its price target of $124 on March 27, 2023. Wells Fargo initiated its recommendation with a Equal Weight and recommended $96 as its price target on March 21, 2023. Jefferies started tracking with a Hold rating for this stock on October 12, 2022, and assigned it a price target of $85.
Conmed Corp experienced fluctuations in its stock price throughout the past year between $59.50 and $86.96. Currently, Wall Street analysts expect the stock to reach $97 within the next 12 months. Conmed Corp [NYSE: CNMD] shares were valued at $59.43 at the most recent close of the market. An investor can expect a potential return of 63.22% based on the average CNMD price forecast.
Analyzing the CNMD fundamentals
Trailing Twelve Months sales for Conmed Corp [NYSE:CNMD] were 1.30B which represents 5.55% growth. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.15 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.94.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 58.56 points at the first support level, and at 57.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 60.73, and for the 2nd resistance point, it is at 62.04.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Conmed Corp [NYSE:CNMD] is 2.30. In addition, the Quick Ratio stands at 1.05 and the Cash Ratio stands at 0.09. Considering the valuation of this stock, the price to sales ratio is 1.41, the price to book ratio is 1.91 and price to earnings (TTM) ratio is 13.98.
Transactions by insiders
Recent insider trading involved Hartman Curt R, Former Officer, that happened on Feb 14 ’25 when 2905.0 shares were purchased. Chief Information Officer, Glaze Richard completed a deal on Feb 11 ’25 to sell 257.0 shares. Meanwhile, Former Officer Hartman Curt R bought 4986.0 shares on Feb 13 ’25.
